Future of Metformin Administration in Sepsis Management
Abstract
No Abstract
Beale R, Reinhart K, Brunkhorst FM, Dobb G, Levy M, Martin G, et al. Promoting Global Research Excellence in Severe Sepsis (PROGRESS): lessons from an international sepsis registry. Infection. 2009; 37(3):222-32.
Brandenburg K, Heinbockel L, Correa W, Lohner K. Peptides with dual mode of action: Killing bacteria and preventing endotoxin-induced sepsis. Biochim Biophys Acta. 2016; 1858(5):971-9.
Mehra IV. Strategies of the treatment of type II diabetes mellitus. Pharm Pract Manag Q. 1997; 17(2):1-11.
Chong RW, Vasudevan V, Zuber J, Solomon SS. Metformin Has a Positive Therapeutic Effect on Prostate Cancer in Patients With Type 2 Diabetes Mellitus. Am J Med Sci. 2016; 351(4):416-9.
Quan H, Zhang H, Wei W, Fang T. Gender-related different effects of a combined therapy of Exenatide and Metformin on overweight or obesity patients with type 2 diabetes mellitus. J Diabetes Complications. 2016; 30(4):686-92.
Hussain M, Atif MA, Ghafoor MB. Beneficial effects of sitagliptin and metformin in non-diabetic hypertensive and dyslipidemic patients. Pak J Pharm Sci. 2016; 29(6(Suppl)):2385-9.
Petrie JR, Chaturvedi N, Ford I, Hramiak I, Hughes AD, Jenkins AJ, et al. Metformin in adults with type 1 diabetes: deign and methods of REducing with MetfOrmin Vascular Adverse Lesions (REMOVAL): an international multicentre trial. Diabetes Obes Metab. 2016.
Jeschke MG, Abdullahi A, Burnett M, Rehou S, Stanojcic M. Glucose Control in Severely Burned Patients Using Metformin: An Interim Safety and Efficacy Analysis of a Phase II Randomized Controlled Trial. Ann Surg. 2016; 264(3):518-27.
Bułdak Ł, Łabuzek K, Bułdak RJ, Machnik G, Bołdys A, Basiak M, et al. Metformin reduces the expression of NADPH oxidase and increases the expression of antioxidative enzymes in human monocytes/macrophages cultured in vitro. Exp Ther Med. 2016; 11(3):1095-1103.
Fruzzetti F, Ghiadoni L, Virdis A, De Negri F, Perini D, Bucci F, et al. Adolescents with Classical Polycystic Ovary Syndrome Have Alterations in the Surrogate Markers of Cardiovascular Disease but Not in the Endothelial Function. The Possible Benefits of Metformin. J Pediatr Adolesc Gynecol. 2016; 29(5):489-95.
Lee SM, Kim SE, Kim EB, Jeong HJ, Son YK, An WS. Lactate Clearance andVasopressor Seem to Be Predictors for Mortality in Severe Sepsis Patients with Lactic Acidosis Supplementing Sodium Bicarbonate: A Retrospective Analysis. PLoS One. 2015; 10(12):e0145181.
Perrone J, Phillips C, Gaieski D. Occult metformin toxicity in three patients with profound lactic acidosis. J Emerg Med. 2011 Mar;40(3):271-5.
Haloob I, de Zoysa JR. Metformin associated lactic acidosis in Auckland City Hospital 2005 to 2009. World J Nephrol. 2016; 5(4):367-71.
DeFronzo R, Fleming GA, Chen K, Bicsak TA. Metformin-associated lactic acidosis: Current perspectives on causes and risk. Metabolism. 2016; 65(2):20-9.
Green JP, Berger T, Garg N, Suarez A, Hagar Y, Radeos MS, et al. Impact of metformin use on the prognostic value of lactate in sepsis. Am J Emerg Med. 2012; 30(9):1667-73.
Doenyas-Barak K, Beberashvili I, Marcus R, Efrati S. Lactic acidosis an severe septic shock in metformin users: a cohort study. Crit Care. 2015; 20:10.
Park J, Hwang SY, Jo IJ, Jeon K, Suh GY, Lee TR, et al. Impact of Metformin Use on Lactate Kinetics in Patients with Severe Sepsis and Septic Shock. Shock. 2016.
Jeon SM. Regulation and function of AMPK in physiology and diseases. Exp Mol Med. 2016; 48(7):e245.
Zakikhani M, Dowling R, Fantus IG, Sonenberg N, Pollak M. Metformin is an AMP kinase-dependent growth inhibitor for breast cancer cells. Cancer Res. 2006; 66(21):10269-73.
Park DW, Jiang S, Tadie JM, Stigler WS, Gao Y, Deshane J, et al. Activation of AMPK enhances neutrophil chemotaxis and bacterial killing. Mol Med. 2013; 19:387-98.
Tzanavari T, Varela A, Theocharis S, Ninou E, Kapelouzou A, Cokkinos DV, et al. Metformin protects against infection-induced myocardial dysfunction. Metabolism. 2016; 65(10):1447-58.
Jian MY, Alexeyev MF, Wolkowicz PE, Zmijewski JW, Creighton JR. Metformin-stimulated AMPK-α1 promotes microvascular repair in acute lung injury. Am J Physiol Lung Cell Mol Physiol. 2013; 305(11):L844-55.
Vaez H, Rameshrad M, Najafi M, Barar J, Barzegari A, Garjani A. Cardioprotective effect of metformin in lipopolysaccharide-induced sepsis via suppression of toll-like receptor 4 (TLR4) in heart. Eur J Pharmacol. 2016; 772:115-23.
Vaez H, Najafi M, Toutounchi NS, Barar J, Barzegari A, Garjani A. Metformin Alleviates Lipopolysaccharide-induced Acute Lung Injury through Suppressing Toll-like Receptor 4 Signaling. Iran J Allergy Asthma Immunol. 2016; 15(6):498-507.
Liu Z, Bone N, Jiang S, Park DW, Tadie JM, Deshane J, et al. AMP-activated protein kinase and Glycogen Synthase Kinase 3β modulate the severity of sepsis-induced lung injury. Mol Med. 2015; 21(1): 937–50.
| Files | ||
| Issue | Vol 3 No 1 (2017): Winter |
|
| Section | Editorial | |
| Keywords | ||
| metformin sepsis experimental model AMP activated protein kinase | ||
| Rights and permissions | |
|
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
